The U.S. Senate has a plan to improve drug development for rare disease patients. The exit of controversial CBER chief Vinay Prasad will help clear the path.

Organoids, assembloids, and organ-on-a-chip technologies represent transformative advances in the fields of drug discovery, precision medicine, and ...

As sponsors advanced more niche and personalized modalities, manufacturers were pushed to adopt holistic approaches to safety ...

Currently, five new compounds are in Phase I or II clinical development, and two “repurposed” drugs are in Phase III development. Progress has been made, particularly with the drug candidate TMC207, ...

Find out how self-driving labs utilise data-driven approaches to enhance drug discovery efficiency and innovation.

Pharmacometrics has long provided a scientific foundation for quantitative decision-making in drug development and therapeutics. Yet, much of its ...

GPCRs are the targets for around one third of all approved drugs 1. Yet such medicines act on only a handful of the 800+ known GPCRs. A wave of biomedical progress in the early 21 st century thrust ...

Creating a drug that might help treat or cure a health condition in humans is a long, complex process. After developing a candidate drug that shows potential—a process that, in and of itself, can take ...

Infrastructure and location have helped make Holly Springs a future hub for obesity drug production, with Amgen and Roche ...

Federal health officials on Monday laid out a proposal to spur development of customized treatments for patients with hard-to ...

Each school year includes nine sessions totaling nine hours of professional development, with one hour of continuing education credit per month. November 20 – National Homeless Youth Awareness Month: ...

Once the active ingredient is defined, an Applicant must select which patent, or patents, to put forward for extension. The statute permits only one PTE per regulatory review period, so the choice is ...